Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the acceptability and experience of receiving diabetes and pregnancy care via telehealth during the COVID-19 pandemic: a qualitative study.

BMC pregnancy and childbirth·2022
Same author

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.

Journal of endocrinological investigation·2021
Same author

The association of smoking status with glycemic control, metabolic profile and diabetic complications- Results of the Australian National Diabetes Audit (ANDA).

Journal of diabetes and its complications·2020
Same author

Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Dental Decay Phenotype in Nonsyndromic Orofacial Clefting.

Journal of dental research·2017
Same author

Spectrum of Dental Phenotypes in Nonsyndromic Orofacial Clefting.

Journal of dental research·2015
Same journal

Cognitive frailty in diabetic patients: A visual analysis based on CiteSpace.

Diabetes research and clinical practice·2026
Same journal

Prevalence, incidence, and 6-years stability of metabolically unhealthy normal weight́s phenotype in u.s. hispanic/latino adults.

Diabetes research and clinical practice·2026
Same journal

Corrigendum to "Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study" [Diabetes Res. Clin. Pract. 222 (2025) 112071].

Diabetes research and clinical practice·2026
Same journal

Health-related quality of life and management routine in painful and painless diabetic polyneuropathy (PREDIP study).

Diabetes research and clinical practice·2026
Same journal

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes.

Diabetes research and clinical practice·2026
Same journal

Independent and combined effects of first-trimester elevated fasting blood glucose and high-normal blood pressure on pregnancy outcomes.

Diabetes research and clinical practice·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Diabetic nephropathy: important pathophysiologic mechanisms.

G Soldatos1, M E Cooper

  • 1Vascular Divsion, Baker IDI Heart and Diabetes Institute, PO Box 6492, St. Kilda Road, Central Melbourne, Victoria 8008, Australia.

Diabetes Research and Clinical Practice
|November 15, 2008
PubMed
Summary
This summary is machine-generated.

Type 2 diabetes is a leading cause of kidney failure. Targeting advanced glycation pathways is crucial for preventing diabetic kidney disease and end-stage renal failure.

Related Experiment Videos

Last Updated: Jun 28, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Type 2 diabetes mellitus is a global epidemic.
  • Diabetes is the primary cause of end-stage renal failure (ESRF) in Western nations.
  • Diabetic nephropathy affects 20-30% of diabetic patients, progressing from microalbuminuria to ESRF.

Purpose of the Study:

  • To highlight the need for novel therapeutic targets in diabetic kidney disease.
  • To emphasize the role of advanced glycation in diabetic renal disease.
  • To reduce the increasing burden of diabetes-related kidney failure.

Main Methods:

  • Review of current literature on diabetic nephropathy.
  • Analysis of pathophysiologic pathways involved in diabetic kidney disease.
  • Discussion of therapeutic strategies, including renin-angiotensin system blockade.

Main Results:

  • Significant advancements in preventing and treating diabetic kidney disease have been made.
  • The renin-angiotensin system blockade is a key therapeutic breakthrough.
  • Advanced glycation is identified as a critical pathophysiologic pathway.

Conclusions:

  • Novel pathways, such as advanced glycation, require further investigation and targeting.
  • Effective management of diabetic kidney disease necessitates addressing multiple pathophysiologic mechanisms.
  • Reducing the incidence of ESRF in diabetic patients remains a critical goal.